Narrative
Schizophrenia affects 1 in 100 people, with costs to society of £12 billion in England alone. Prevalence is similar across the world, with two thirds of people experiencing relapses despite medical treatment. Researchers at the University of Manchester (UoM) pioneered and disseminated psychological interventions for schizophrenia and related mental health problems which have led to improved outcomes for patients and families (e.g. 20% improvement in symptoms over standard treatment). We have implemented and delivered our intervention protocols, outcome measures, treatment manuals, and training programmes (with over 200 training courses delivered across the UK, Europe, USA, Asia, Australia and Africa). The impact of the research has been commended nationally and internationally by professional bodies (e.g., British Psychological Society, American Association of Behavior Therapy).Impact date | 2014 |
---|---|
Category of impact | Health impacts, Societal impacts, Economic impacts |
Impact level | Benefit |
Documents & Links
Related content
-
Research output
-
Cognitive-behavioural therapy v. social activity therapy for people with psychosis and a history of violence: Randomised controlled trial
Research output: Contribution to journal › Article › peer-review
-
Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: Acute-phase outcomes
Research output: Contribution to journal › Article › peer-review
-
Group cognitive-behavioural therapy for schizophrenia: Randomised controlled trial
Research output: Contribution to journal › Article › peer-review
-
Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial
Research output: Contribution to journal › Article › peer-review
-
Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: Randomised controlled trial
Research output: Contribution to journal › Article › peer-review